Note 19 — Income Taxes

The Company elected to be treated as a corporation, for tax purposes, effective January 1, 2018. The following table details the Company’s income tax expense (benefit):

 

 

December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(In thousands)

 

Current tax expense (benefit):

 

 

 

 

 

 

 

 

 

Federal

 

$

37,228

 

 

$

27,810

 

 

$

13,631

 

State

 

 

12,163

 

 

 

11,546

 

 

 

2,509

 

Total current tax expense

 

 

49,391

 

 

 

39,356

 

 

 

16,140

 

Deferred tax expense (benefit):

 

 

 

 

 

 

 

 

 

Federal

 

 

(6,372

)

 

 

(8,396

)

 

 

1,654

 

State

 

 

(1,762

)

 

 

(3,035

)

 

 

1,040

 

Total deferred tax expense (benefit)

 

 

(8,134

)

 

 

(11,431

)

 

 

2,694

 

Total income tax expense

 

$

41,257

 

 

$

27,925

 

 

$

18,834

 

The following table contains a reconciliation of the Company’s provision for income taxes at the federal statutory tax rate to the provision for income taxes at the effective tax rate as of December 31, 2025, 2024 and 2023 after the adoption of ASU 2023-09:

 

 

December 31,

 

 

 

2025

 

2024

 

2023

 

 

 

($ in thousands)

 

Federal income tax provision at statutory rate

 

$

30,726

 

 

 

21.00

 

%

 

$

20,225

 

 

 

21.00

 

%

 

$

15,699

 

 

 

21.00

 

%

 

State and local effects (1)

 

 

8,452

 

 

 

5.78

 

 

 

 

6,714

 

 

 

6.97

 

 

 

 

4,626

 

 

 

6.19

 

 

 

Tax credits

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and Development Credit

 

 

(288

)

 

 

(0.20

)

 

 

 

(248

)

 

 

(0.26

)

 

 

 

(145

)

 

 

(0.19

)

 

 

Nontaxable or Nondeductible Items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share based compensation (2)

 

 

1,852

 

 

 

1.27

 

 

 

 

1,231

 

 

 

1.28

 

 

 

 

449

 

 

 

0.60

 

 

 

Other

 

 

82

 

 

 

0.06

 

 

 

 

29

 

 

 

0.03

 

 

 

 

19

 

 

 

0.03

 

 

 

Change in unrecognized tax benefit

 

 

24

 

 

 

0.02

 

 

 

 

(56

)

 

 

(0.06

)

 

 

 

(1,739

)

 

 

(2.33

)

 

 

Other

 

 

409

 

 

 

0.27

 

 

 

 

30

 

 

 

0.03

 

 

 

 

(75

)

 

 

(0.10

)

 

 

Effective tax rate

 

$

41,257

 

 

 

28.20

 

%

 

$

27,925

 

 

 

28.99

 

%

 

$

18,834

 

 

 

25.20

 

%

 

(1)
For tax year 2024, state taxes in California made up the majority (greater than 50 percent) of the tax effect in this category. For tax years 2025 and 2023, state taxes in California and New Jersey made up the majority (greater than 50 percent) of the tax effect in this category.
(2)
Included in Share based compensation is windfalls related to restricted stock awards, short falls related to nonqualified restricted stock options, reversal of employee stock purchase plan expense, and non-deductible executive compensation under IRC §162(m).

Net cash paid (refunds received) for income taxes consisted of the following:

 

 

2025

 

 

2024

 

 

2023

 

 

 

(In thousands)

 

Federal

 

$

37,608

 

 

$

30,712

 

 

$

5,360

 

State and local jurisdiction

 

 

13,128

 

 

 

10,837

 

 

 

2,288

 

California

 

 

5,234

 

 

 

5,774

 

 

 

850

 

Other States

 

 

7,894

 

 

 

5,063

 

 

 

1,438

 

Net cash paid for income taxes

 

$

50,736

 

 

$

41,549

 

 

$

7,648

 

The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities as of December 31, 2025 and 2024 are presented below:

 

 

December 31,

 

 

 

2025

 

 

2024

 

 

 

(In thousands)

 

Deferred tax assets:

 

 

 

 

 

 

REMIC book-tax basis difference

 

$

19,342

 

 

$

9,220

 

Mark-to-market on loans

 

 

95

 

 

 

 

Lease liability

 

 

846

 

 

 

779

 

Stock compensation

 

 

715

 

 

 

834

 

Accrued bonus

 

 

136

 

 

 

144

 

Accrued vacation

 

 

544

 

 

 

521

 

Intangibles

 

 

 

 

 

1

 

REO

 

 

894

 

 

 

207

 

Research and experimental expenditures capitalization

 

 

 

 

 

2,241

 

Derivative - OCI

 

 

1,233

 

 

 

294

 

Deferred revenue

 

 

995

 

 

 

1,053

 

Deferred state taxes

 

 

 

 

 

510

 

Deferred origination costs

 

 

88

 

 

 

 

Gross deferred tax assets

 

 

24,888

 

 

 

15,804

 

Deferred tax liabilities:

 

 

 

 

 

 

Mark-to-market on loans

 

 

 

 

 

(172

)

Right-of-use assets

 

 

(770

)

 

 

(721

)

Deferred origination costs

 

 

 

 

 

(108

)

Property and equipment

 

 

(71

)

 

 

(157

)

Deferred state taxes

 

 

(146

)

 

 

 

MSR

 

 

(156

)

 

 

(246

)

Other

 

 

(1,036

)

 

 

(788

)

Gross deferred tax liabilities

 

 

(2,179

)

 

 

(2,192

)

Total net deferred tax asset

 

$

22,709

 

 

$

13,612

 

The Company’s main temporary difference is due to the difference between the U.S. income tax and U.S. GAAP treatment with respect to its REMIC securities. For tax purposes, the issuances are considered taxable sales, whereas, for U.S. GAAP purposes, the REMIC issuances are considered financings.

The Company had no valuation allowance as of December 31, 2025 and 2024. Based on the Company’s estimates of taxable income over the years in which the items giving rise to the deferred tax assets are deductible, management believes it is more likely than not the Company will realize the benefits of these deductible differences.

The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates. In the normal course of business, the Company is subject to examination by federal, state, and local jurisdictions, where applicable. As of December 31, 2025, the Company is no longer subject to U.S. tax examinations for years before 2022 and is no longer subject to state tax examinations for years before 2021.

The Company periodically reviews its income tax positions based on tax laws and regulations and financial reporting considerations, and records adjustments as appropriate. This review takes into consideration the status of

current taxing authorities’ examinations of the Company’s tax returns, recent positions taken by the taxing authorities on similar transactions, if any, and the overall tax environment.

The Company had gross unrecognized tax benefits in the amount of $0.3 million and $0.3 million recorded as of December 31, 2025 and 2024, respectively. If recognized, $0.3 million of the unrecognized tax benefits would affect the 2025 annual effective tax rate. Interest and penalties on unrecognized tax benefits is reported by the Company as a component of tax expense, and the Company recorded interest and penalties in its Consolidated Statements of Income in the amount of $7 thousand, $1 thousand and $500 thousand for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025 and 2024, the accrued interest and penalties related to unrecognized tax benefits is $41 thousand and $34 thousand, respectively.

Detailed below is a reconciliation of the Company’s gross unrecognized tax benefits for the years ended December 31, 2025, 2024 and 2023, respectively:

 

 

December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(In thousands)

 

Beginning balance

 

$

305

 

 

$

390

 

 

$

1,940

 

Changes related to current year tax positions

 

 

59

 

 

 

61

 

 

 

93

 

Changes related to prior year tax positions

 

 

13

 

 

 

(33

)

 

 

25

 

Decreases due to lapsed statutes of limitations

 

 

(60

)

 

 

(113

)

 

 

(1,668

)

Ending balance

 

$

317

 

 

$

305

 

 

$

390

 

Historical Timeline

Fiscal YearFiled
2025Mar 12, 2026Showing above
2024Mar 12, 2025
2023Mar 15, 2024
2022Mar 13, 2023
2021Mar 15, 2022
2020Mar 17, 2021

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.